Xenter, Inc.
Records under this name other than the patents Xenter, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.
Showing 1 to 4 of 4 · Back to Xenter, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,446,047 | Substituted 2,3-dihydro-1H-inden-1-one Retinoic acid-related orphan nuclear receptor Antagonists for Treating Multiple Sclerosis Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,172,866 | Substituted 2,3-dihydro-1H-inden-1-one Retinoic acid-related orphan nuclear receptor Antagonists for Treating Multiple Sclerosis Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,682,358 | Substituted 2, 3-Dihydro-1H-INDEN-1-ONE Retinoic Acid-Related Orphan Nuclear Receptor Antagonists for Treating Multiple Sclerosis Formerly held In force · High confidence | In force | High confidence | |
| US 9,359,315 | Substituted 2,3-dihydro-1H-inden-1-one Retinoic acid-related orphan nuclear receptor Antagonists for Treating Multiple Sclerosis Formerly held In force · High confidence | In force | High confidence |